The unrestricted use of paclitaxel- versus sirolimus-eluting stents for coronary artery disease in an unselected population

The universal use of PES in an unrestricted setting is safe and is associated with a similar adjusted outcome compared to SES. The inferior trend in crude outcome seen in PES was due to its higher-risk population. A larger, randomized study enrolling an unselected population may assist in determining the relative superiority of either device.